Jasper Therapeutics, Inc. · NASDAQ:JSPR

T. Rowe Price Investment Management, Inc. reported a 7.10% stake in Jasper Therapeutics, Inc. (Schedule 13G)

Event Sep 30, 2025 · Filed Nov 14, 2025

T. Rowe Price Investment Management, Inc. reported a 7.10% stake in Jasper Therapeutics, Inc., 2,057,612 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).

Stake
7.10%
Shares
2,057,612
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
T. Rowe Price Investment Management, Inc.7.10%2,057,612

Source

View original at SEC

Related